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Approximately 15,500 nursing homes provide a mixture of short-term skilled nursing and 
long-term custodial care to millions of frail and older persons each year in the United States. 
While on a given day, there are an estimated 1.4 million U.S. nursing home residents, over 
the course of a year, more than 2 million individuals enter nursing homes for short-term, 
skilled nursing and rehabilitation services. The prevalence of latent tuberculosis infection 
(LTBI) among frail and older adults in long-term care facilities (LTCFs) is unknown, and 
likely varies greatly, depending on the patient population. Because the majority of 
tuberculosis (TB) cases in the United States are the result of remote infection (i.e., infection 
in the distant past), persons with LTBI represent a reservoir of persons in whom TB can be 
prevented. Among older adults, an estimated 90% of TB cases result from reactivation of 
LTBI acquired earlier in life, rather than as a result of recent transmission.[1, 2] Older adults 
are at highest risk because they are more likely to have been exposed to TB at some point 
during their lifetime. This increased risk results from more years during which exposure 
might have occurred and having lived through a time when TB was more common. Even as 
TB disease incidence rates have declined, the population with LTBI continues to grow.[3–5] 
In 2014, 2.2% of cases of TB disease were among persons diagnosed in LTCFs.[6] As the 
proportion of U.S. adults aged ≥65 years continues to expand, populations residing in long 
term care settings will include disproportionate numbers of persons both at risk for TB and 
for progression to active TB disease if LTBI is untreated.
Despite state and federal guidelines recommending LTBI testing for populations with a high 
risk for LTBI and TB transmission, including those living in LTCFs, Reddy and colleagues 
report that only 63% of residents in three inner-city LTCFs in the Boston area received LTBI 
testing despite those facilities serving a population at high risk (e.g., 48% with diabetes, 
38% foreign-born, and 33% with chronic kidney disease).[7] Upon closer examination, one 
facility apparently accounted for the greatest proportion of missed testing opportunities, with 
only 28% of eligible residents tested; however, none of the three facilities had 100% testing 
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for eligible residents, even among residents staying 3 months or longer as recommended by 
Massachusetts TB guidance in effect at the time of that study.[7] This potential gap in LTBI 
detection is of particular concern, given that among persons with tuberculin skin test (TST) 
results, the prevalence of LTBI was 20%, including 8% with a new positive TST result 
documented during the current LTCF stay.[7] An additional 8% had documentation of a TST 
being performed, but no result was documented.[7] The variation in LTBI testing practices 
observed in this limited study should prompt providers and public health officials to evaluate 
LTBI testing practices in their own communities.
From Reddy’s assessment, how LTCF residents with prior positive or new positive TST 
results were evaluated for TB is unclear, particularly among persons with a history of remote 
infection. Residents with a positive TST should have a medical examination, including chest 
radiograph, to rule out active TB before being offered LTBI treatment. Screening for LTBI 
requires complete evaluation for TB; if the evaluation results are positive for LTBI, patients 
should be referred for appropriate treatment. For residents with known positive results, 
documenting infection status also allows consideration of TB in differential diagnoses for 
patients who exhibit nonspecific TB symptoms (e.g., weight loss, cough, or fever). Reddy 
reports that four of 12 residents with newly documented positive LTBI test results during 
admission were offered LTBI treatment, of whom three completed therapy; however, no 
information was available for those with positive results before LTCF admission.[7] 
Facilities providing long-term care services need to have a process for follow-up of residents 
who are identified with LTBI. The need to develop an LTBI testing and treatment protocol 
should also be a consideration for other long-term care service providers, including adult day 
service centers, home health agencies, and assisted living communities, all of which provide 
care to an additional 7 million U.S. residents each year.[8]
Although the LTBI prevalence rates observed among residents admitted to the three 
participating facilities in Reddy’s study might not be representative for all LTCFs nationally, 
changing demographics and increased comorbidities among residents might contribute to 
increased risk for TB disease in long-term care settings. The racial/ethnic diversity in LTCFs 
has been increasing, with the proportion of white, non-Hispanic residents having decreased 
from 84% in 2004 to 76% in 2014.[8–10] Frailty and care needs are also increasing, with 
63% of persons requiring assistance with four or more daily living activities and 32% 
requiring assistance because of diabetes.[8, 10] Growth in the short-stay, recently 
hospitalized population has also contributed to the medical complexity of the LTCF 
population. As the medical complexity and comorbid conditions in these settings increase, 
so might the potential for development of active TB and outbreaks among residents. 
Outbreaks in LTCFs are associated with preventable transmission and mortality, and they 
necessitate extensive contact investigation efforts.[11–13]
With the availability of shorter course, better tolerated LTBI treatment regimens, 
opportunities for preventing TB disease and transmission among older adults are substantial.
[14–16] However, prevention cannot be implemented if the population at risk is undetected. 
CDC and the U.S. Preventive Services Task Force recommend LTBI screening for 
asymptomatic adults at increased risk for TB, including those who have lived in countries 
with increased TB prevalence and those who live in or have lived in high-risk congregate 
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settings (e.g., homeless shelters, LTCFs, and correctional facilities).[17, 18] LCTFs and 
other long-term care service providers have an opportunity to contribute to TB elimination 
by implementing consistent LTBI testing for new admissions, evaluating persons with 
positive LTBI results for TB disease, and offering treatment and ongoing follow-up for 
treatment completion. Providers who take actions now to improve testing and treatment 
practices for LTBI among frail and older residents will have substantial impact on the 
morbidity and mortality experienced from active TB disease and unrecognized transmission 
potential among this vulnerable population.
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